The Board of Directors of Celltrion, Inc. has authorized a buyback plan on April 17, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
190,900 KRW | +0.05% | -1.80% | -5.26% |
May. 10 | Celltrion's Q1 Attributable Profit Slumps 86% | MT |
Apr. 24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.26% | 28.85B | |
+28.99% | 49.18B | |
+0.82% | 42.11B | |
+50.47% | 40.37B | |
+13.30% | 26.09B | |
-22.63% | 18.71B | |
+8.06% | 13.26B | |
+32.17% | 12.32B | |
-0.52% | 11.99B | |
+24.26% | 11.97B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion, Inc. authorizes a Buyback Plan.